Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study. - Douma, Li-Anne H; Lalezari, Ferry; van der Noort, Vincent; de Vries, Jeltje F; Monkhorst, Kim; Smesseim, Illaa; Baas, Paul; Schilder, Bodien; Vermeulen, Marrit; Burgers, Jacobus A; de Gooijer, Cornedine J (Lancet Oncology, 2023)